PLEKHG2

Recombinant BXH2 and AKXD inbred mice mutated by retroviral transduction are known to develop myeloid leukemia, B cell and T cell leukemia at high frequency.[5]

In 2002, Himmel et al., used this model of acute myelogenous leukemia and showed that a novel Dbl family guanine nucleotide exchange factor gene is contained downstream of the retroviral uptake site called Evi24. They named this gene Clg. Hemmel and colleagues cloned Clg and showed homology with PLEKHG2 contained in human chromosome 19 chromosome 19q13.1 region. From these observations they pointed out association with acute myeloid leukemia.[6]

In a paper published by Hemmel et al., in 2002, they showed that a construct containing a DH-PH domain of Clg promotes guanine nucleotide exchange of Cdc42 but does not promote guanine nucleotide exchange of Rac1 or RhoA. In addition, DH-PH domains or full-length Clg were introduced into NIH3T3 cells and transformation occurred.

Later, Ueda and his colleagues introduced the expression construct of full-length human PLEKHG2 into HEK 293 cells. In this cell the Gβγ subunit of the trimeric G protein were interacted with PLEKHG2 directly. Ueda and colleagues also showed that PLEKHG2 were activated by Gbg and PLEKHG2 activates Rac1, Cdc42 of RhoGTPase and contributes to cell morphological change.[7]

In 2013, Runne et al., showed that PLEKHG2 is elevated in several leukemia cell lines, including Jurkat T cells. In addition, they showed that GPCR signal-dependent activation of Rac and Cdc42 regulates the chemotaxis of lymphocytes via actin polymerization. From this observation PLEKHG2 was considered to an important regulator of cell motility.[8]

Furthermore, in recent years, it has become clear that PLEKHG2 undergoes regulation through modification such as phosphorylation and interaction with other proteins by various intracellular signals (see the section on interaction / protein modification). However, the function in vivo is still unclear.

In 2016, Edvardson et al., identified homozygosity for Arg204Trp mutation in the PLEKHG2 gene in the patients with dystonia or postnatal microcephaly.[9]

PLEKHG2 is known to interacted with the following proteins.

・Gβγ[7]

・β-actin[10]

・Four and a Half LIM domain1 (FHL1)[11][12]

・Gαs[13]

It is known that PLEKHG2 undergoes modification such as phosphorylation by the following signals.

・SRC[14]

・EGFR[15]